Michel De La Brassinne

Centre Hospitalier Universitaire Centre Ville
Liege, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study.

Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study.

Journal: Advances in therapy

Published: May 28, 2023

Decision-making factors for the long-term topical treatment of mild-to-moderate plaque psoriasis: TEPPSO, a case-vignette study on clinical practice.

Decision-making factors for the long-term topical treatment of mild-to-moderate plaque psoriasis: TEPPSO, a case-vignette study on clinical practice.

Journal: Annales de dermatologie et de venereologie

Published: October 26, 2021

Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study.

Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study.

Journal: Advances in therapy

Published: September 17, 2021

Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study.

Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study.

Journal: JAAD international

Published: August 19, 2021

Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study.

Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 15, 2020

Duality of Netherton syndrome manifestations and response to ixekizumab.

Duality of Netherton syndrome manifestations and response to ixekizumab.

Journal: Journal of the American Academy of Dermatology

Published: February 18, 2020

A Belgian consensus on the definition of a treat-to-target outcome set in psoriasis management.

A Belgian consensus on the definition of a treat-to-target outcome set in psoriasis management.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 29, 2019

Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective.

Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective.

Journal: The Journal of dermatological treatment

Published: September 30, 2015

Psoriasis: state of the art 2013.

Psoriasis: state of the art 2013.

Journal: Acta clinica Belgica

Published: March 19, 2014

Psoriasis: state of the art 2013.

Psoriasis: state of the art 2013.

Journal: Acta clinica Belgica

Published: March 19, 2014

Profile of the Belgian dermatologist: results of an online survey.

Profile of the Belgian dermatologist: results of an online survey.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 24, 2013

A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO).

A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO).

Journal: European journal of dermatology : EJD

Published: January 24, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026